It has been conclusively demonstrated that IVF outcomes with GnRH antagonists are comparable to those with GnRH agonists, with the added advantage of a significantly reduced risk of OHSS [14,15,16,17,18,19,20,21]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.